Search Results - cell+therapy%2fimmunotherapy

3 Results

Sort By:

Extracellular Matrix Scaffolds for Combination Immunotherapy

Unmet NeedThe critically important goal of regenerative medicine is the stimulation of in vivo wound healing and the production of functional tissue to repair or replace tissues loss to injury or disease. Extracellular matrix (ECM) materials are acellular tissue derived scaffolds commonly used in tissue regeneration following malignant or benign tumor...

Published: 9/26/2024 | Inventor(s): Jennifer Elisseeff, Matthew Wolf

Keywords(s): Cancers, Cell Therapy/Immunotherapy, Combination, Disease Indication, Implanted Device, Implants, Therapeutic Devices, Therapeutic Matter, Therapeutics, Therapy Type, Tissue Engineering/Regenerative Devices

Category(s): Clinical and Disease Specializations > Immuno-Oncology, Technology Classifications > Therapeutic Modalities > Immunotherapies, Technology Classifications > Medical Devices > Regenerative Medicine

Host Defense Turned Viral Offense; Engineering the Next Generation of Oncolytic Adenoviruses

C10910: Use of RNA Interference and Adenovirus Therapy against Prostate CancerValue Proposition: • Addresses a major patient need • Enhances the therapeutic efficacy of CRAd strategy • Creates the bases to develop enhanced oncolytic viral gene therapies with shRNA Technical Details: Prostate cancer is one of the most aggressive cancers...

Published: 9/26/2024 | Inventor(s): Naser Hoti, Ronald Rodriguez

Keywords(s): Biologics, Cancers, Cell Therapy/Immunotherapy, Combination, Disease Indication, Drug Delivery Vehicle, Nucleic Acid, Plasmid/Vector, Prostate Cancer, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Men's Health, Clinical and Disease Specializations > Oncology > Prostate Cancer, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Therapeutic Modalities > Cell Therapies, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Immunotherapies, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities

Modulation of systemic Immune Responses by Transplantation of Hemotopoietic Stem Cells Transduced with Genes Encoding Antigens and Antigen Presenting Cell Regulatory Molecules

C03855: Modulation of Systemic Immune Responses by Transplantation of Hemotopoietic Stem Cells Transduced with Genes Encoding Antigens and Antigen Presenting Cell Regulatory Molecules Technical Details: The initiation of T cell-dependent immune responses depends on presentation of antigens by bone marrow-derived antigen-presenting cells such as...

Published: 9/26/2024 | Inventor(s): Yan Cui, Katherine Whartenby, Linzhao Cheng, Curt Civin, Drew Pardoll

Keywords(s): Biologics, Cancers, Cell Therapy/Gene Therapy, Cell Therapy/Immunotherapy, Combination, Disease Indication, Nucleic Acid, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type, Whole cell

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Therapeutic Modalities > Cell Therapies, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Immunotherapies, Technology Classifications > Therapeutic Modalities